Hydroxocobalam 1000mcg/ml Inj, 30ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into a muscle. If you will be self-administering the injection, your doctor or nurse will provide guidance on the proper technique. Before and after handling the medication, wash your hands thoroughly. Do not use the medication if the solution appears cloudy, is leaking, or contains particles, or if the solution has changed color. Dispose of used needles in a designated needle/sharp disposal box, and do not reuse needles or other items. When the disposal box is full, follow local regulations for proper disposal. If you have any questions or concerns, consult with your doctor or pharmacist.
Storing and Disposing of Your Medication
In most cases, this medication will be administered in a hospital or doctor's office. If you need to store it at home, follow the storage instructions provided by your doctor. Protect the medication from light and keep it in a safe location, out of the reach of children and pets.
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed dose.
Lifestyle & Tips
- Maintain a balanced diet, but understand that dietary intake alone may not be sufficient if the deficiency is due to malabsorption (e.g., pernicious anemia).
- Regular follow-up appointments and blood tests are crucial to monitor treatment effectiveness and adjust dosing if needed.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Swelling
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ An irregular heartbeat
Other Possible Side Effects
Like all medications, this drug can cause side effects. Although many people do not experience any side effects or only have mild ones, it is essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other unusual symptoms that bother you or do not go away, contact your doctor:
Diarrhea
* Irritation at the injection site
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Persistent fatigue or weakness
- Numbness or tingling in hands or feet
- Difficulty walking or balance problems
- Memory issues or confusion
- Sore, red tongue
- Unexplained weight loss
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This information will help your doctor and pharmacist assess potential interactions between this medication and other substances you are taking.
* Any existing health problems, as this medication may interact with certain conditions.
To ensure your safety, it is crucial to verify that it is safe to take this medication with all your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Generally considered to have very low toxicity, even at high doses.
- Possible mild, transient side effects like headache, nausea, diarrhea, or rash.
- Very rare: allergic reactions.
What to Do:
Discontinue drug if severe allergic reaction occurs. Otherwise, supportive care. Call 1-800-222-1222 (Poison Control) for advice if concerns arise.
Drug Interactions
Moderate Interactions
- Chloramphenicol (may antagonize hematologic response to B12 in anemic patients)
- Folic acid (large doses may mask B12 deficiency symptoms)
Minor Interactions
- Metformin (can decrease B12 absorption)
- Proton pump inhibitors (PPIs) (can decrease B12 absorption with long-term use)
- H2-receptor antagonists (can decrease B12 absorption with long-term use)
- Colchicine (can decrease B12 absorption)
- Neomycin (can decrease B12 absorption)
- Aminosalicylic acid (can decrease B12 absorption)
Monitoring
Baseline Monitoring
Rationale: To confirm diagnosis of deficiency.
Timing: Prior to initiation of therapy.
Rationale: To assess severity of anemia (macrocytic, megaloblastic) and monitor hematologic response.
Timing: Prior to initiation of therapy.
Rationale: To monitor for hypokalemia, which can occur during initial treatment of severe megaloblastic anemia due to increased cellular uptake of potassium.
Timing: Prior to initiation of therapy and during the first few days of treatment for severe cases.
Rationale: To confirm B12 deficiency (elevated levels) and monitor biochemical response.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Weekly for the first month, then monthly until stable, then as clinically indicated.
Target: Normalization of red blood cell indices (MCV), hemoglobin, and reticulocyte count.
Action Threshold: Lack of hematologic response or worsening anemia.
Frequency: 3-6 months after initiation of maintenance therapy, then annually or as clinically indicated.
Target: Within normal range (e.g., >200 pg/mL or higher depending on lab and clinical context).
Action Threshold: Persistently low levels despite therapy, indicating malabsorption or inadequate dosing.
Frequency: Regularly during initial treatment and maintenance.
Target: Improvement or stabilization of neurological symptoms (e.g., paresthesias, gait disturbance).
Action Threshold: Worsening or new neurological symptoms.
Symptom Monitoring
- Fatigue
- Weakness
- Pale skin
- Sore tongue (glossitis)
- Paresthesias (tingling, numbness in hands/feet)
- Difficulty walking or balance issues
- Memory problems or cognitive changes
- Mood changes (irritability, depression)
Special Patient Groups
Pregnancy
Vitamin B12 is essential during pregnancy. While hydroxocobalamin is generally considered safe and necessary for treating deficiency, it is classified as Category C for therapeutic doses due to limited controlled studies. However, the benefits of treating B12 deficiency in pregnancy generally outweigh potential risks.
Trimester-Specific Risks:
Lactation
Vitamin B12 is excreted into breast milk and is essential for infant development. Hydroxocobalamin is considered compatible with breastfeeding (L1 - Safest) as it is a natural form of the vitamin and necessary for both mother and infant.
Pediatric Use
Dosing must be carefully adjusted based on age, weight, and severity of deficiency. Essential for normal growth and neurological development. Long-term treatment may be required for congenital deficiencies.
Geriatric Use
Elderly patients are at higher risk for B12 deficiency due to age-related malabsorption (e.g., atrophic gastritis, decreased intrinsic factor). Dosing is generally similar to adults, but careful monitoring of neurological status and B12 levels is important.
Clinical Information
Clinical Pearls
- Hydroxocobalamin is often preferred over cyanocobalamin for B12 deficiency due to its longer retention in the body and absence of cyanide moiety.
- Parenteral administration (IM or SC) is crucial for patients with malabsorption syndromes (e.g., pernicious anemia, gastrectomy, Crohn's disease) where oral absorption is impaired.
- Initial treatment of severe megaloblastic anemia with B12 can cause hypokalemia due to rapid cellular uptake of potassium; monitor serum potassium levels.
- Neurological symptoms of B12 deficiency may be irreversible if treatment is delayed.
- Folic acid supplementation can mask the hematological signs of B12 deficiency while allowing neurological damage to progress; always rule out B12 deficiency before treating megaloblastic anemia with folic acid alone.
Alternative Therapies
- Cyanocobalamin (another synthetic form of Vitamin B12, available orally, IM, SC, intranasally)
- Methylcobalamin (active form of Vitamin B12, available orally, sublingually)
- Adenosylcobalamin (active form of Vitamin B12, less commonly used as a supplement)